ALB and hepatocellular carcinoma: Albumin ISH demonstrated 99% sensitivity for HCC, with 92 of 93 cases exhibiting positive staining, significantly exceeding the performance of traditional immunohistochemical markers, HepPar1 and Arg-1, which showed sensitivities of 84% and 83%, respectively.